Editorial: Type 2 inflammatory skin diseases: novel therapies and clinical insights

• by Linfeng Li

• June 18, 2026

Is Kaposi’s sarcoma the end of the OX40/OX40L axis in atopic dermatitis?

• by Shahram Salek-Ardakani

• June 2, 2026

AAD Issues Pediatric Atopic Dermatitis Guidelines

Two companion guidelines provide 41 evidence-based recommendations on treatment and prevention, along with 29 statements on comorbidity associations in patients under 18

• by Kerri Miller

• April 8, 2026

• 6 min

Case Report: Ivarmacitinib in the treatment of refractory primary cutaneous amyloidosis

• by Xiaofan Liao, Xian Huang, Guilan Yang, Xia Wang, Qifeng Li, Yuan Lu

• May 8, 2026